DocGo Inc (DCGO)vsFresenius Medical Care Corporation (FMS)
DCGO
DocGo Inc
$0.64
-4.44%
HEALTHCARE · Cap: $66.57M
FMS
Fresenius Medical Care Corporation
$22.26
+1.04%
HEALTHCARE · Cap: $12.47B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 5992% more annual revenue ($19.63B vs $322.20M). FMS leads profitability with a 5.0% profit margin vs -56.6%. FMS earns a higher WallStSmart Score of 62/100 (C+).
DCGO
Hold36
out of 100
Grade: F
FMS
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for DCGO.
Margin of Safety
+73.4%
Fair Value
$90.32
Current Price
$22.26
$68.06 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
Grey zone — moderate risk
Smaller company, higher risk/reward
Weak financial health signals
ROE of -89.0% — below average capital efficiency
4.2% earnings growth
Grey zone — moderate risk
ROE of 7.9% — below average capital efficiency
5.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : DCGO
The strongest argument for DCGO centers on Price/Book, Debt/Equity.
Bull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.
Bear Case : DCGO
The primary concerns for DCGO are Altman Z-Score, Market Cap, Piotroski F-Score.
Bear Case : FMS
The primary concerns for FMS are EPS Growth, Altman Z-Score, Return on Equity. Thin 5.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
DCGO profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.
DCGO carries more volatility with a beta of 0.96 — expect wider price swings.
FMS is growing revenue faster at -0.3% — sustainability is the question.
FMS generates stronger free cash flow (564M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (62/100 vs 36/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DocGo Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DocGo Inc. is an innovative mobile healthcare service provider revolutionizing patient access through its advanced logistics and telehealth platform. Specializing in urgent care, diagnostic testing, and health screenings, the company enhances patient experiences while streamlining healthcare delivery across diverse environments. With strong technological integration and a commitment to expanding quality healthcare access, DocGo is well-positioned for substantial growth in the rapidly evolving healthtech sector, making it an attractive investment opportunity for institutional investors.
Visit Website →Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?